Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin vs Oral Hypoglycemic Agents in Gestational Diabetes Mellitus
NCT07582471Completed
- Sponsor
- Dr Mudassar Saeed Pansota
- Start
- Oct 2025
- Primary completion
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin and liquid metformin (Aspargo Labs) in gestational diabetes mellitus (GDM) (2 arms), sponsored by Dr Mudassar Saeed Pansota. Primary endpoint: Percentage of Neonatal Hypoglycemia at 24 hours. Started Oct 2025; status: completed.
02
Drugs
human insulinliquid metformin (Aspargo Labs)
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT07582471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07582471.